EpigeneticsRx, a Case Study in Personalized Health and Patient Empowerment

April 21, 2021 @ 5:30 pm – 7:00 pm

Precision Health & Wellness:

EpigeneticsRx, a Case Study in Personalized Health and Patient Empowerment

Wednesday, April 21st, 2021 @ 5:30pm PST (1.5 hours)


Meeting info provided upon registration.

Join the MIT Enterprise Forum San Diego on April 21st as we present an intriguing Personalized Medicine Case Study.  Debra Hubers, CEO and Founder of EpigeneticsRx, will present her business case for investment to a panel that includes a fellow entrepreneur, life science investor, and healthcare and health policy executive.

EpigeneticsRX is a San Diego based start-up that has developed a Personalized Medicine Platform that combines testing, personalized formulations, and a premium health and wellness membership concept.  This unique combination has the potential to empower both patients and providers to turn a patient’s personal DNA profile into actionable health plans customized to optimize results.  If successful, a Personalized Medicine market opportunity greater than $5 trillion awaits, but with plenty of competition of all types.

Questions and challenges remain as always.  The Panel, in this case acting as a Board of Directors, will explore these challenges, such as:

  • How best to scale the business given its unique B:B:C business model?
  • How to drive adoption?
  • To what extent could this or should this be an “out licensing play”?
  • Is the investment ask appropriate given the competitive landscape?

Join the MITEF San Diego on April 21st for what will prove to be an enlightening discussion!


Zeynep Ilgaz, founder of Confirm Biosciences

Zeynep Ilgaz is an immigrant from Turkey and has been living in San Diego for over 20 years.

She is the founder of Confirm Biosciences, a national provider of diagnostic products for human and wellness testing. Under her leadership, the company landed among the INC 5000 Fastest Growing Company list- (3 years in a row with over 800% growth rate) as well as SDBJ Fastest growing company list. The Company was recently acquired by CRL. (Clinical Reference Laboratory)

As part of her efforts to give back to the community, Ilgaz started a “We Care, People over Profit” Corporate Program within Confirm Biosciences- where a percentage of sales has been contributed to giving back to local organizations.

She currently serves on the Advisory Board of the Lavin Entrepreneur Center at SDSU, and was formerly on the Board of Directors for Interfaith Health Services. She has also served on the NIH Commercialization Assistance Program for Small Businesses.

Ilgaz received her MBA from San Diego State University in 2000. She earned her bachelor’s degree in Economics and Finance from Bosphorus University, Istanbul, Turkey.

Mrs. Ilgaz served as a contributor to outlets such as Entrepreneur, Forbes and Huffington Post, where she has talked about growth and leadership as well as creativity and positivity.

She has been married to the love of her life for 24 years, they have 2 boys and 4 dogs.



Debra Hubers, Co-Founder of EpigeneticsRx

Debra Hubers is a serial entrepreneur and has started seven businesses; ranging from an advanced genomic support company to an employer healthcare purchasing cooperative. Deb has over 35 years of experience in healthcare finance, education, technology and pharmacogenomics.

Ms. Hubers has dedicated her career to measuring and improving healthcare outcomes. Her expertise is leveraging technology to deliver personalized, preventative medicine. Ms. Hubers co-founded La Vita Compounding Pharmacy in 2007. Collaborating with her business partner, physicians and strategic partners, Deb has grown La Vita to be one of the most respected and sought after personalized medicine providers on the west coast. She is also Co-Founder of EpigeneticsRx, a leading provider of precise, personalized, prevention which positively impacts genetic expression. Deb founded her first preventative health care business in 1984 and has spent her career as both an entrepreneur and executive of public companies including Bank One and Imperial Bank. It was Deb’s role at the Alliance in 1990, a business coalition of self-funded employers, where Deb’s passion for healthcare outcome data analysis, self-funded health plans and corporate health was first ignited. This foundation led her to develop additional skills in healthcare finance, healthcare electronic payment systems and pharmacogenomics. La Vita has been honored from 2011 through 2015 as one of the Fastest Growing Private Companies by the San Diego Business Journal, awarded the SBA Women Owned Small Business of Year for San Diego and Riverside Counties in 2012 and the SBA Creativity and Growth Award in 2015. The National Association of Woman Business Owners awarded Ms. Hubers the BRAVO Trailblazer award in 2012 and the Woman Business Owner of the Year in 2015. EpigeneticsRx was selected as one of SCORE’s American Small Business Champions in 2016.

Deb has an undergraduate degree from Minnesota State University and a Masters of Arts degree from the University of Northern Colorado. She taught at the University of Colorado, Denver University and Bastyr University San Diego. Ms. Hubers currently serves as the past Chair of the Board of Trustees for Bastyr University, Board of Directors of the Kids Eco Club and is a member of the Institute for Natural Medicine’s Leadership Counsel.

In her spare time, she enjoys skiing, yoga, hiking and spending time with her family (both genetic and by friendship).


Killu Sanborn, Ph.D., Managing Director, Oxford Finance, LLC

Killu Sanborn has over 25 years of experience as a venture debt and venture equity investor, banker, executive, entrepreneur and researcher. She was previously, Managing Director of Hercules Technology Growth Capital, Senior VP at Comerica Bank, and Principal/Fund Manager with IngleWood Ventures, Director of Technology Commercialization at Stratagene, and first employee and VP of Business Development of Phenogenex. As venture debt provider and VC, she has funded tens of California life science and medical technology companies. Her Ph.D. in Molecular Biology is from Weill Cornell Graduate School of Medical Sciences/Sloan-Kettering Institute.


Elizabeth Dreicer, Co-Founder & CEO, Consuli, Inc.

Elizabeth Dreicer is a CEO, philanthropist and activist. She is co-founder and investor in a number of software, analytics, data, film/story and impact organizations. Elizabeth is a creative leader and builder—of organizations, coalitions, and systems. Her experience spans enterprise, social enterprise, and foundation realms; start-ups, transformations, scaling (including roll ups) through sale.

Dreicer received her Bachelor’s of Science degree in Organizational Leadership from Pennsylvania State University. She is also a graduate of Singularity University’s Exponential Medicine (previously FutureMed) Executive Program and Extreme Leadership Executive Programs.

As Trustee of the Alliance Healthcare Foundation (AHF) and previous Board Chair, Dreicer is a member of the Nominating and Governance Committee, Program Committee, Finance/Investment Committee (where she is presently Vice Chair and immediate past Chair), and the Impact Investing Committee.

Further, Elizabeth has served on numerous nonprofit boards, including, 211 San Diego and Just in Time for Foster Youth (where she was a founding member). She is also a member and Co-Director of the E2 (environmental entrepreneurs) San Diego chapter, a national nonpartisan business leader group affiliated with NRDC (National Resource Defense Coalition) that advocates for good economic and environmental policies. Elizabeth is also part of SingularityU San Diego Chapter leadership.

Finally, she is involved in efforts to evolve stakeholder capitalism and design the future. Elizabeth is devoted to bridging and developing systems and solutions to improve life.



Visit Our Website to stay updated on future programs.


We look forward to connecting with you,

The Chapter Executive Committee & Advisory Board
MIT Enterprise Forum-San Diego Chapter